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Abstract— The spinal cord is the major dose- limiting organ 
for radiotherapy of cancer in the head and neck region. Un-
derstanding the cellular and molecular mechanisms may help 
to develop strategies to either increase the radiation tolerance 
or to treat spinal cord alterations induced by irradiation. 
Radiation exposure leads to oxidative stress and necrosis in 
many cell types including neurons. Radiation – induced apop-
tosis has also been observed in animal models. The exact me-
chanism and the genes that are activated in the process of 
radiation- induced apoptosis has not established yet. However 
many events that occur at the cell surface and intracellular 
during apoptosis in the nervous system have been reported.
There is literature to support possible roles for TNF- Į DV D
contributor to apoptosis in the CNS. In the last decade, there 
have been reports on the anti apoptotic effect of melatonin, an 
endogenous compound mainly synthesized by the pineal gland 
in the human brain. The purpose of this study was to investi-
gate changes in TNF- ĮJHQHH[SUHVVLRQ in the spinal cord after 
neck irradiation with 22 Gy. In addition, we evaluated the 
ability of melatonin to modulate the radiation - induced TNF-
Į gene expression in this animal model of spinal cord irradia-
tion. A number of rats were divided into four groups: 1. Con-
trol group; 2. Group that was treated with intraperitonial 
injection of melatonin; 3.Group of rats which got melatonin 30
min. prior to cervical spinal cord gamma irradiation at a dose 
of 22 Gy; and 4.Group that was given an intraperitonial injec-
tion of vehicle and the spinal cord radiation. The expression of 
TNF- Įwas evaluated by real time reverse transcription poly-
merase chain reaction (Real time RT-PCR). The finding indi-
cates that melatonin down-regulates the TNF- Į gene expres-
sion in the spinal cord in response to radiation.
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INTRODUCTION
Most patients who are currently diagnosed with head and 
neck malignancy will receive a course of radiotherapy for 
cure or for local control or symptomatic palliation.[1] The 
potential consequences of damaging healthy spinal cord 
within the radiation field can be severe and limit the dose of 
radiation which can be delivered to tumors in this region.
Almost 40% of patients who received cumulative radiation 
doses of 60 Gy showed histological evidence of radio ne-
crosis at the time of rebiopsy.[2] Severity of clinical symp-
toms of radiation myelopathy depends on the level and the 
affected region of spinal cord and it may be not diagnosed 
from the associated symptoms alone. The underlying me-
chanisms of this injury remain unclear, however, there is an 
increasing body of data indicating that the response of the 
CNS after irradiation is a continuous, dynamic, and interact-
ing process.[3] TNF-Į has already been introduced as a 
potential trigger for apoptosis. However, depending on the 
context, this protein appears capable of exerting opposite 
effects on oligodendrocyte apoptosis. Most studies have 
demonstrated primarily toxic effects, leading to apoptosis in 
several different models. In addition, TNF- ĮH[HUWVLQSDr-
ticular pro inflammatory  effects by inducing the expression 
of  adhesion molecules that recruit leukocytes into the sites 
of tissue damage, by priming  leukocytes for oxidant pro-
duction, and by inducing production of prostaglandins and 
other mediators of inflammation. Also, TNF- ĮH[HUWVILEUo-
genic effects by stimulating the growth of fibroblasts and 
increasing the collagen deposition.[4] Therefore, a pharma-
cological regulation of the TNF- ĮSURGXFWLRQDW WKH LQLWLDO
stage could possibly modulate the progression of radiation-
induced injury. In the last decade, there have been reports 
on the radioprotective effect of melatonin, an endogenous 
compound mainly synthesized by the pineal gland in the 
human brain. Melatonin (Nacetyl-5-methoxytryptamine) is 
a ubiquitously acting molecule with several functions. It is 
highly lypophilic and somewhat water-soluble. The wide-
spread cellular distribution of melatonin may allow it to 
interact with all molecules, thereby reducing the oxidative 
damage to molecules in both lipid and aqueous environ-
ments of the cell. It has been reported that melatonin direct-
ly scavenges the highly toxic hydroxyl radicals both in vitro 
and in vivo, as well as several other reactive species such as 
single oxygen, peroxynitrite anion.[5] Its free radical–
scavenging capacity is mediated by electron donation. Sev-
eral studies have shown that melatonin reduces chronic and 
acute inflammation.[6,7,8,9] The immunomodulatory and 
antiapoptotic properties of melatonin are well known; it acts 
on the immune system by regulating cytokine production of 
immunocompetent cells.[10] Experimental and clinical data 
showing that melatonin reduces adhesion molecules and 
pro-inflammatory cytokines and modifies serum inflamma-
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tory parameters. After SCI, TNF- Į might serve as an exter-
nal signal, initiating apoptosis in neurons and oligodendro-
cytes. The inhibition of the MMP-2, and MMP-9 by mela-
tonin is most likely attributed to the suppressive effect on 
TNF- Į production.[11] The results of different studies 
indicate that both the acute and the chronic toxicities of 
melatonin are extremely low.
I. MATERIAL AND METHOD
The rats were divided into four groups. The first group 
(vehicle treatment) served as control. The second group 
(radiation) was treated with vehicle and 30 min later, the 
rats were exposed to radiation, which will be detailed in the 
following section. The third group (radiation+melatonin) 
was given an intraperitonial injection of melatonin (100
mg/kg body weight) and 30 min later exposed to radiation
in the same manner as in the second group. The fourth 
group (melatonin-only) was also given an intraperitonial 
injection of melatonin (100 mg/kg body weight). 
Irradiation 
The animals were anesthetized with an i.p injection of 
ketamin (60 mg/kg) and xylazin (20 mg/kg). Then, they 
were placed in a prone position. The rats of groups 2 and 3
were irradiated with the gamma beam of Cobalt-60 telethe-
rapy unit (theratron 760-C) to the 1.8 cm cervical segment 
of the spinal cord (C1-T2). A single dose of 22 Gy at the 
dose rate of 1.8 Gy/min and source skin distance of 79.5cm
was administered to the depth of 0.5 cm based on lateral 
simulation radiographs. This dose is proposed as the “Effec-
tive Dose” for white matter necrosis and limb paralysis after 
20 weeks of irradiation.[12] Sham irradiation was also per-
formed for control and melatonin-only groups. The rats 
were anesthetized, but were not irradiated. The animals 
were scarified under ketamine and xylazine injection chro-
nologically in 4 and 24 hours, and 1, 3, 8, 16, 20, and 22
weeks after radiation therapy. Five rats were used at each 
time point. Tissue sampling was done through posterior 
approach to cervical spinal cord. One centimeter of spinal 
cord was dissected and used for real time RT-PCR study. 
To this purpose, the spinal cord was embedded in GITC (6
molar) for the inactivation of enzymes and RNase-free con-
ditions, and then homogenized by Heidolf Homogenizer. 
All samples were stored at -70o C until required.
The PCRs were carried out in a reaction volume of 25 L
consisting of 5 L cDNA, 20 pmol of each primer, and 12.5
L PCR-mix. Thermal cycling was initiated with an initial 
denaturation step of 94 °C for 3 min and followed by the 
thermal profile of 94 °C (20 s) + 55 °C (30 s) + 72 °C (40 s) 
for 40 cycles in a Stratagen real-time system. A suitable 
threshold was applied to amplification plots, and the result-
ing Ct values (threshold cycles) were used for relative quan-
tification. The Ct values of VEGF were normalized accord-
ing to the Ct values of ȕ-actin, and the resulting values were 
compared with those of the control group using a 2-ǻǻFW
method.
II. RESULTS
After a single dose of 22 Gy, TNF- Į JHQH H[SUHVVLRQ
was measured in the experimental groups, it was defined 
proportionate with the age-matched controls after 4 and 24
hours and 1, 3 , 8, 16, 20 and  22 weeks after irradiation 
(fig. 1). At the early time after irradiation, Radiation did not 
induce elevations in TNF- Į JHQH H[SUHVVLRQ in the irra-
diated group.
Within 3 weeks after irradiation, TNF- Į gene upregu-
lated 3 fold in the irradiated group compared with the con-
trol group(p<0.05). TNF- Į expression in the irradiated 
group decreased over time as the interval after radiation is 
extended to 22 weeks. Within 16 and 20 weeks after irradia-
tion, the expression of VEGF gene in the irradiated group 
was same as the control group. TNF- Į expression in mela-
tonin pretreatment group compared with the radiation group 
is significantly down-regulated at the 3 weeks after irradia-
tion (p<0.05). There is not any difference between the con-
trol and melatonin-only groups. 
III. CONCLUSIONS
TNF- Į is released in the beginning of the immune re-
sponse to endotoxin, physical injury and a variety of in-
flammatory processes. Up to now two major apoptosis me-
diating cascades have been analyzed in greater detail. The 
first pathway activated by radiation and cellular stress. Rad-
iation induced apoptosis primarily relies on mitochondrial 
damage followed by caspase activation. Bax can induce 
release of pro-apoptotic molecules including cytochrome c 
and apoptosis inducing factor (AIF). The release of cytoch-
rome c triggers the activation of caspase-9 via APAF-1 and 
dATP. The second pathway of apoptosis is mediated by 
members of the death ligand family including TNF- Į, 
CD95-l, and TRAIL. After activation of a death receptor 
(i.e. TNFȐ-R1) the adapter FADD mediates activation of 
caspase-8. Adhering leukocytes may increase the vessel 
toxicity via TNF- Į induced apoptosis.[4] TNF- ȐKDVEHHQ
shown to induce apoptosis in oligodendrocytes both in vitro 
and in vivo. Melatonin as a neuroprotector has used in some 
model of CNS injury. Neuroprotective effect of melatonin 
in Spinal cord injuries due to trauma, hypoxia, ischemia, 
and toxic agent have been shown by other researchers in the 
short time after injury.[10,13,14] It has been postulated that 
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in addition to scavenging the free radical
tonin can preserve mitochondrial homeos
vasoconstriction in CNS arterioles. The ex
melatonin mediated to modulate TNF- Į
unclear. Probably, the regulation of TNF-
and in addition to the antioxidative effec
tional factors may be involved in the regu
gene expression by melatonin. Reiter note
does not function exclusively as a free rad
antioxidant, but may have other functions
and organisms to cope with metabolic dis
ple, melatonin can influence NFkB, a mu
scription factor that is capable of influen
genes.[14] The precise role of melatonin 
regulation and neuroprotection after irradi
determined.
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